Anti-tumor necrosis factor therapy is associated with increased in situ squamous cell carcinoma of the skin: A population-based case-control study.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Adalsteinsson, Jonas AMuzumdar, Sonal
Waldman, Reid
Hu, Chaoran
Wu, Rong
Ratner, Désirée
Ungar, Jonathan
Silverberg, Jonathan I
Olafsdottir, Gudridur H
Kristjansson, Arni Kjalar
Tryggvadottir, Laufey
Jonasson, Jon Gunnlaugur
Issue Date
2020-11-27
Metadata
Show full item recordCitation
Adalsteinsson JA, Muzumdar S, Waldman R, Hu C, Wu R, Ratner D, Ungar J, Silverberg JI, Olafsdottir GH, Kristjansson AK, Tryggvadottir L, Jonasson JG. Anti-tumor necrosis factor therapy is associated with increased in situ squamous cell carcinoma of the skin: A population-based case-control study. J Am Acad Dermatol. 2021 Jun;84(6):1760-1762. doi: 10.1016/j.jaad.2020.11.029.Description
To access publisher's full text version of this article click on the hyperlink belowae974a485f413a2113503eed53cd6c53
10.1016/j.jaad.2020.11.029
Scopus Count
Collections
Related articles
- Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: A population-based case-control study.
- Authors: Adalsteinsson JA, Muzumdar S, Waldman R, Hu C, Wu R, Ratner D, Ungar J, Silverberg JI, Olafsdottir GH, Kristjansson AK, Tryggvadottir L, Jonasson JG
- Issue date: 2021 Mar
- An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factors.
- Authors: van Lümig PP, Menting SP, van den Reek JM, Spuls PI, van Riel PL, van de Kerkhof PC, Fransen J, Kievit W, de Jong EM
- Issue date: 2015 Apr
- Lack of Increased Risk of Lymphoma by Thiopurines or Biologics in Japanese Patients with Inflammatory Bowel Disease: A Large-Scale Administrative Database Analysis.
- Authors: Kobayashi T, Uda A, Udagawa E, Hibi T
- Issue date: 2020 Jun 19
- Lack of association between a disease-susceptible single-nucleotide polymorphism, rs2230926 of <i>TNFAIP3</i>, and tumour necrosis factor inhibitor therapeutic failure in Japanese patients with rheumatoid arthritis.
- Authors: Matsuoka H, Kabata D, Taura A, Matsui T, Takahi K, Hirano F, Katayama M, Okamoto A, Suenaga Y, Suematsu E, Yoshizawa S, Ohmura K, Ito S, Takaoka H, Oguro E, Kuzuya K, Okita Y, Udagawa C, Yoshimura M, Teshigawara S, Harada Y, Isoda K, Yoshida Y, Ohshima S, Tohma S, Saeki Y
- Issue date: 2020 May
- Risk of non-melanoma skin cancer for rheumatoid arthritis patients receiving TNF antagonist: a systematic review and meta-analysis.
- Authors: Wang JL, Yin WJ, Zhou LY, Zhou G, Liu K, Hu C, Zuo XC, Wang YF
- Issue date: 2020 Mar